skip to main | skip to sidebar

SeguraBlawg's Autoimmunity-Inflammation Blawg

Monday, April 12, 2010

BioMed Central | Full text | Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: Effect on eosinophil density and activation in relation to pharmacokinetics

BioMed Central Full text Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: Effect on eosinophil density and activation in relation to pharmacokinetics
Posted by Jacob N. Segura at 8:29 PM

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

Followers

Blog Archive

  • ►  2013 (4)
    • ►  April (4)
  • ►  2011 (1)
    • ►  May (1)
  • ▼  2010 (13)
    • ►  September (1)
    • ►  June (5)
    • ▼  April (6)
      • Leukotriene Receptor Antagonists: Leukotriene Rece...
      • The Role of Leukotrienes in Inflammation — Ann Int...
      • NEJM -- Montelukast, a Leukotriene-Receptor Antago...
      • BioMed Central | Full text | Montelukast in the tr...
      • Age-Induced Reprogramming of Mast Cell Degranulati...
      • Mast Cells: Masterminds of Allergic Disease
    • ►  February (1)
  • ►  2009 (20)
    • ►  June (3)
    • ►  May (3)
    • ►  March (2)
    • ►  February (4)
    • ►  January (8)
  • ►  2008 (9)
    • ►  December (9)

About Me

Jacob N. Segura
View my complete profile